Heartbeam Inc (BEAT)vsTempus AI, Inc. Class A Common Stock (TEM)
BEAT
Heartbeam Inc
$0.41
-0.97%
HEALTHCARE · Cap: $22.90M
TEM
Tempus AI, Inc. Class A Common Stock
$59.01
+0.46%
HEALTHCARE · Cap: $11.66B
Smart Verdict
WallStSmart Research — data-driven comparison
BEAT leads profitability with a 0.0% profit margin vs -17.8%. TEM earns a higher WallStSmart Score of 28/100 (F).
BEAT
Avoid21
out of 100
Grade: F
TEM
Avoid28
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 21.6% year-over-year
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
0.0% earnings growth
Trading at 23.9x book value
ROE of -57.2% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BEAT
The strongest argument for BEAT centers on Price/Book.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 21.6% demonstrates continued momentum.
Bear Case : BEAT
The primary concerns for BEAT are Revenue Growth, EPS Growth, Market Cap.
Bear Case : TEM
The primary concerns for TEM are EPS Growth, Price/Book, Return on Equity. Debt-to-equity of 3.25 is elevated, increasing financial risk.
Key Dynamics to Monitor
BEAT profiles as a value stock while TEM is a growth play — different risk/reward profiles.
TEM carries more volatility with a beta of 3.72 — expect wider price swings.
TEM is growing revenue faster at 21.6% — sustainability is the question.
BEAT generates stronger free cash flow (-4M), providing more financial flexibility.
Bottom Line
TEM scores higher overall (28/100 vs 21/100) and 21.6% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Heartbeam Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
BioTelemetry, Inc., a remote medical technology company, provides remote heart monitoring, remote blood glucose monitoring, centralized central laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research clients throughout the world. The company is headquartered in Malvern, Pennsylvania.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?